Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G Messenger

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Dermatology|January 26, 2023
Alopecia areata and risk of common infections: a population-based cohort studyAndrew G Messenger, Matthew Harries, Abby E Macbeth, et al.
Clinical and Experimental Dermatology|January 23, 2023
Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort studySusan Holmes, Matthew Harries, Abby E Macbeth, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unitM Julie Thornton, Anthony H Taylor, Kellie Mulligan, et al.
Journal of Drugs in Dermatology : JDD|July 9, 2016
Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded StudyUlrike Blume-Peytavi, Jerry Shapiro, Andrew G Messenger, et al.
The British Journal of Dermatology|February 14, 2022
The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary careAbby E Macbeth, Susan Holmes, Matthew Harries, et al.
Plos One|September 10, 2019
Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Plos One|July 6, 2019
Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Human Immunology|July 11, 2006
The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areataE Helen Kemp, Andrew J G McDonagh, David A Wengraf, et al.
Dermatology Research and Practice|September 4, 2018
Whole Genome Sequencing in an Acrodermatitis Enteropathica Family from the Middle EastFaisel Abu-Duhier, Vivetha Pooranachandran, Andrew J G McDonagh, et al.
The Journal of Investigative Dermatology|July 18, 2009
Keratin K6c mutations cause focal palmoplantar keratodermaNeil J Wilson, Andrew G Messenger, Sancy A Leachman, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Dermatology|January 26, 2023
Alopecia areata and risk of common infections: a population-based cohort studyAndrew G Messenger, Matthew Harries, Abby E Macbeth, et al.
Clinical and Experimental Dermatology|January 23, 2023
Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort studySusan Holmes, Matthew Harries, Abby E Macbeth, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unitM Julie Thornton, Anthony H Taylor, Kellie Mulligan, et al.
Journal of Drugs in Dermatology : JDD|July 9, 2016
Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded StudyUlrike Blume-Peytavi, Jerry Shapiro, Andrew G Messenger, et al.
The British Journal of Dermatology|February 14, 2022
The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary careAbby E Macbeth, Susan Holmes, Matthew Harries, et al.
Plos One|September 10, 2019
Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Plos One|July 6, 2019
Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the diseaseFatma N Hamed, Annika Åstrand, Marta Bertolini, et al.
Human Immunology|July 11, 2006
The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areataE Helen Kemp, Andrew J G McDonagh, David A Wengraf, et al.
Dermatology Research and Practice|September 4, 2018
Whole Genome Sequencing in an Acrodermatitis Enteropathica Family from the Middle EastFaisel Abu-Duhier, Vivetha Pooranachandran, Andrew J G McDonagh, et al.
The Journal of Investigative Dermatology|July 18, 2009
Keratin K6c mutations cause focal palmoplantar keratodermaNeil J Wilson, Andrew G Messenger, Sancy A Leachman, et al.
Pageof 4